FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS. Eureka Journal of Health Sciences & Medical Innovation, [S. l.], v. 2, n. 6, p. 1–11, 2026. Disponível em: https://eurekaoa.com/index.php/5/article/view/1148. Acesso em: 16 jun. 2026.